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Abstract  29 
Acrylamide is a substance that can be neurotoxic in humans and experimental animals. It is 30 
formed at different rates in starchy foods cooked at temperatures above 120°C as a result of 31 
interaction between monosaccharides and the amino acid asparagine. Carnosic acid 32 
accounts for over 90% of the antioxidant properties of rosemary extract and is a powerful 33 
inhibitor of lipid peroxidation in microsomal and liposomal systems. Carnosic acid has been 34 
shown to protect against oxidative and inflammatory effects. In order to investigate the 35 
protective properties of carnosic acid against acrylamide-induced toxicity in human retinal 36 
pigment epithelium (RPE) cells, ARPE-19 cells were pre-treated with 10µM CA for 24h 37 
followed by treatment with acrylamide (0.7 or 1 mM) for 24h.  ARPE-19 cells pre-treated with 38 
10µM carnosic acid showed significantly increased cell viability and decreased cell death rate 39 
when compared to ARPE-19 cells treated with acrylamide alone. Activities of SOD and 40 
catalase and the level of GSH and expression of NRF2 and a number of anti-oxidant genes 41 
were significantly decreased in ARPE-19 cells, while there were significant increases in ROS 42 
and MDA; pre-treatment with carnosic acid significantly counteracted these changes. Our 43 
results suggest that carnosic acid protected RPE cells from acrylamide-induced toxicity. 44 
 45 
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1. Introduction 57 
Acrylamide (Fig. 1E) is a highly water-soluble white substance with a solid crystalline form 58 
(Becalski et al., 2003; Exon, 2006). The main application of acrylamide and polyacrylamides 59 
is in the manufacture of plastics and in the welding of waterpipes, although they are also 60 
used in the production of paper and textiles. In addition, acrylamide monomer is used in the 61 
preparation of polyacrylamide electrophoresis gels in research and clinical diagnosis labs 62 
(Dybing et al., 2005). Acrylamide is also formed in starchy foods such as fried potatoes, 63 
bread, cookies, and coffee heated to temperatures above 120°C (Tareke et al., 2002; 64 
Kahkeshani et al., 2015). Generally, the formation of acrylamide during cooking at high 65 
temperatures is due to the reaction between the amino acid asparagine and a carbonyl-66 
containing source (Zyzak et al., 2003). Jakobsen et al. (2016) estimated that the mean 67 
dietary intake of acrylamide in the Danish population is 0.27 µg/kg bw/day (females) and 0.36 68 
µg/kg bw/day (males). Two earlier studies estimated that the Dutch population had a slightly 69 
higher mean acrylamide exposure of 0.48 (Konings et al., 2003) and 0.5 (Boon et al., 2005) 70 
µg/kg bw/day. Similar to that of the Dutch population, the US population had an estimated 71 
mean acrylamide exposure of 0.44 µg/kg bw/day (Doerge et al., 2008). The major 72 
contribution to dietary intake of acrylamide is French-fries /fried potatoes (Boon et al., 2005; 73 
Doerge et al., 2008; Dybing and Sanner, 2003; Jakobsen et al., 2016; Svensson et al., 74 
2003). Acrylamide is classified as a potential carcinogen, one possible reason being its 75 
genotoxicity (Dobrovolsky et al., 2016; EFSA, 2015; Meil et al., 2008; Mei et al., 2010). 76 
Rodents with oral exposure to acrylamide experienced tumours in various organs (EFSA, 77 
2015) while humans exposed to acrylamide have an increased risk of developing cancer 78 
(EFSA, 2015).       79 
         Acrylamide was identified as a neurotoxin about 60 years ago (Kuperman, 1958). 80 
Humans and laboratory animals exposed to acrylamide exhibited neurotoxicity characterised 81 
by ataxia, weight loss, skeletal muscle weakness, and distal swelling and degeneration of 82 
axons in the peripheral and central nervous systems (LoPachin and Decaprio, 2005; El-83 
Tantawi, 2007). The retina is a part of the central nervous system and contains three main 84 
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layers: photoreceptor layer, inner nuclear layer and ganglion cell layer (Patnaik et al, 2015). 85 
The retina is responsible for receiving light and converting it to neural signals that are passed 86 
to the brain for visual processing. Early studies showed that chronic exposure of monkeys 87 
(Macaca nemestrina) to acrylamide led to significantly reduced visual function (Merigan et 88 
al., 1985) and degeneration of ganglion cells, although the inner nuclear and photoreceptor 89 
layers were preserved (Eskin et al., 1985; Eskin and Merigan, 1986). Maternal exposure of 90 
rat to acrylamide caused massive structural abnormalities in outer and inner nuclear layers 91 
and degeneration of ganglion cells in retinas of offspring at age 7 and 14 days (Sakr et al., 92 
2011). Adult rats administered with acrylamide (15 mg/kg body weight) for 28 days exhibited 93 
a significant reduction in amplitude of electroretinogram a and b waves (Ali et al., 2014).    94 
      Carnosic acid (Fig. 1E) is a phenolic diterpene extracted from rosemary (Rosmarinus 95 
officinalis) and has shown antioxidative activity (Aruoma et al., 1992; Wu et al., 2015), anti-96 
inflammatory activity (Lin et al., 2014), anticarcinogenic activity (Cortese et al., 2016; Russo 97 
et al., 2009), and antibacterial activity (Vázquez et al., 2016). Carnosic acid is characterized 98 
by its lipid solubility and its expulsion of free radicals of oxygen, hydroxyl, and lipid peroxyl. 99 
Therefore, it prevents the oxidation of lipids and the rupture of biological membranes 100 
(Aruoma et al., 1992; Haraguchi et al., 1995). It has been reported that carnosic acid 101 
prevents the accumulation of the protein cysteine and reduces meta-fat oxidation, thus 102 
slowing the rate of free radical formation and thereby protecting cells from damage (Poeckel 103 
et al., 2008; Sozio et al., 2008). Additionally, carnosic acid has been reported to induce the 104 
transcriptional activation of antioxidant Nrf2/ARE pathway, which may be involved in the 105 
protective effects of carnosic acid in chronic neurodegenerative conditions like Parkinson's 106 
disease (Bahri et al., 2016). 107 
      Retinal pigment epithelium (RPE) cells lie beneath the photoreceptor layer in the retina 108 
and maintain the function of photoreceptors by helping to renew photoreceptor outer 109 
segments and by providing nutrition to photoreceptors (Strauss, 2005). In the current study 110 
we investigated the toxicity of acrylamide to RPE cells and evaluated the protective effects of 111 
carnosic acid against acrylamide-induced toxicity. 112 
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2. Materials and methods 113 
2.1 Cell Culture 114 
Adult human retinal pigment epithelium ARPE-19 cells (ATCC® CRL-2302™) were grown in 115 
Dulbecco's Modified Eagle Medium (DMEM/F12, Lonza, UK) comprising 2.4 mM L-116 
Glutamine, 17.5mM glucose, and supplemented with 10% fetal bovine serum (FBS, Lonza), 117 
100μg/mL streptomycin, and 100 units/mL penicillin (Lonza, UK) and 0.26% sodium 118 
bicarbonate (Sigma).  119 
 120 
2.2 Cell viability 121 
ARPE-19 cells were seeded in a clear 6-well tissue culture plate (Greiner Bio One, UK) for 122 
24 hours at a density of 3 ×105 cells/well. To test cytoprotective effects of carnosic acid to 123 
acrylamide-induced cell death, cells were pretreated with 10μM of carnosic acid (Cat. 124 
Number C0609, purity>91%, Sigma) dissolved in Dimethyl sulfoxide (DMSO, Sigma) for 24 125 
hours in serum-free medium. Cells were then treated with acrylamide (0.7 and 1mM) for 24 126 
hours. Cells were stained with 0.2% crystal violet (Sigma, UK). The absorbance was 127 
measured at 570nm in a microplate spectrophotometer Epoch reader (Biotech, UK). The 128 
percentage of viable cells was determined using the following formula: 129 
% of viable cells = [(absorbance of untreated cells - absorbance of treated cells) / 130 
absorbance of untreated cells] ×100. 131 
 132 
2.3 Measurement of reactive oxygen species (ROS)  133 
 ARPE-19 cells (25,000/well) were seeded in clear-bottomed black 96-well tissue culture 134 
plates (Greiner Bio One, UK) and cultured for 24 hours. Cells were then treated with carnosic 135 
acid (10µM), while control cells were treated with 0.1% DMSO alone for 24 hours. Cells were 136 
washed twice with PBS (200 µl/well), then treated with acrylamide (0.7 and 1mM) for 24 137 
hours. Total ROS was measured using the 6-Carboxy-2′,7′-Dichlorofluorescin diacetate 138 
(DCFH-DA) (Sigma, UK) according to the manufacturer’s guidelines. Briefly, a stock solution 139 
of 10 mM of DCFH-DA was prepared in DMSO, then cells were incubated with 10 µM DCFH-140 
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DA in PBS (150µl/well) and incubated for 30 minutes in 5% CO2 incubator at 37°C. The 141 
fluorescence was measured at 485 nm (excitation) and 525 nm (emission) using a Fluostar 142 
Optima microplate reader (BMG-labtech).  143 
 144 
2.4 Quantitative real-time polymerase chain reaction (qRT-PCR) 145 
Total RNA was isolated using Trizol Reagent (Sigma, UK) according to the manufacturer’s 146 
protocol. cDNA was synthesized using a High-Capacity cDNA Reverse Transcription Kit with 147 
RNase Inhibitor (Applied Biosystems, UK). The quantification of gene expression was 148 
detected by qRT-PCR assay using a Platinum® SYBR® Green QPCR SuperMix-UDG 149 
w/ROX kit (Invitrogen, UK). The relative change in gene expression was determined 150 
according to 2-ΔΔCT formula (Livak and Schmittgen, 2001) in which gene expression was 151 
normalized to expression of the housekeeping gene, β-actin, in the treated and control 152 
samples. The sequences of primers used in qRT-PCR are listed in Table 1.  153 
 154 
2.5. Measurement of catalase (CAT) and superoxide dismutase (SOD) activities 155 
CAT and SOD activities were detected in ARPE-19 cells using the SOD Detection Kit 156 
(OxiSelect Superoxide Dismutase Activity Assay Kit; Cell Biolabs, STA-340) and the 157 
OxiSelect Catalase Activity Assay Kit (Cell Biolabs, STA-341), according to the 158 
manufacturer’s instructions. 159 
 160 
2.6 Quantification of glutathion and malondialdehyde   161 
Quantitation of glutathion (GSH) and malondialdehyde (MDA) in treated and control ARPE-162 
19 cells was measured using the total glutathion (GSSG/GSH) assay kit (Cell Biolabs, STA-163 
312) and TBARS Assay kit ( for MDA) (Cell Biolabs, STA-330) according to the 164 






2.7 Western blotting assay 169 
Control and treated ARPE-19 cells were lysed with ice-cold RIPA lysis buffer (Thermo 170 
Scientific), the lysates were collected and centrifuged, and the supernatants were stored at   171 
-80°C until required. Protein concentration was determined using Precision Red Advanced 172 
Protein Assay reagent (Cytoskeleton, Inc. Cat. # ADV02-A) according to the manufacturer’s 173 
guidelines. Proteins were run in SDS-PAGE and transferred to nitrocellulose membrane 174 
(Amersham Biosciences).  The membrane was blocked by incubation in 5% milk powder in 175 
Tris-Buffered Saline-Tween 20 buffer for 1 hour at room temperature, followed by incubation 176 
with primary antibodies (GAPDH and NRF2, 1:1000 dilution) overnight at 4°C. The 177 
membrane was washed and incubated with secondary antibodies (1:10000 dilution). The 178 
signals were detected using the LI-COR Odyssey FC Imaging System and the signal 179 
intensity was analyzed by Image Studio™ Lite analysis software (LI-COR).  180 
 181 
2.8 Detection of cell death 182 
Cell death was detected using DeadEndTM fluorometric TUNEL assay kit (Promega) following 183 
the manufacturer’s instructions. Briefly, treated and control ARPE1-9 cells were fixed with 4% 184 
PFA for 20 minutes at 4°C and washed with PBS once, followed by permeabilisation with 185 
0.2% Triton X-100 in PBS for 5 min. Cells were labelled with rTDT reaction mix for one hour 186 
at 37°C and the reaction was stopped with 2X SSC. Cells were rinsed with PBS and 187 
mounted using Vectashield mounting media containing DAPI (Vector laboratories). Images 188 
were captured using ZEISS LSM 800 confocal microscopy. To quantify cell death, the 189 
number of TUNEL positive cells in 300 cells was counted from three individual samples (100 190 
cells in each sample). 191 
 192 
2.9 Statistical Analysis 193 
Statistical analysis was carried out using GraphPad Prism 6 software. All data were obtained 194 
from three independent experiments using one-way ANOVA test. Data are presented as 195 
means ± standard error.  196 
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3. Results  197 
 3.1 Acrylamide treatment resulted in decreased RPE cell viability that was 198 
significantly counteracted by carnosic acid 199 
To investigate the effect of acrylamide-induced toxicity in RPE cells, cell viability was 200 
assessed by crystal violet staining (Fig. 1D). Cell viability of ARPE-19 cells was significantly 201 
decreased to 65.55%, 50.05%, and 36.37% of untreated levels following exposure to 0.7, 202 
1.0, or 2.0mM acrylamide respectively (Fig. 1A). ARPE-19 exposed to acrylamide at 0.37 203 
and 0.5mM showed no significant reduction in cell viability. Prior to investigating the 204 
protective effect of carnosic acid on acrylamide exposure, we assessed cell viability of 205 
ARPE-19 cells treated with carnosic acid at 10, 20, 30, 40, 50, and 60µM and found that cell 206 
viability was significantly decreased when treated with carnosic acid of 40, 50 or 60µM but 207 
was not significantly changed when treated with carnosic acid at 10, 20 or 30µM (Fig. 1B). 208 
Consequently, acrylamide at concentrations of 0.7 and 1.0mM and carnosic acid at 209 
concentration of 10µM were used for subsequent experiments. ARPE-19 cells first treated 210 
with carnosic acid (10µM) for 24 h and then exposed to 0.7 or 1mM acrylamide for 24 h 211 
demonstrated significantly increased cell viability by 12.21% and 14.25% respectively when 212 
compared with cells treated with acrylamide alone (Fig. 1 C, D).  213 
 214 
3.2 Carnosic acid protects against acrylamide-induced cell death in RPE cells 215 
We examined whether reduced cell viability is associated with apoptotic cell death. We used 216 
TUNEL staining to assess the cell death (Fig. 2A) and found that there was a significantly 217 
increased cell death rate in ARPE-19 cells exposed to 0.7 and 1mM acrylamide when 218 
compared to untreated control cells and that pre-treatment with carnosic acid led to 219 
significant reduction in cell death induced by acrylamide (Fig. 2B). 220 
      We also measured the expression of cell death related genes, caspase-3 and caspase-9 221 
(Fig. 3). Acrylamide treatment (0.7 and 1mM) resulted in significantly increased expression of 222 
caspase-3 and caspase-9 genes when compared to the control ARPE-19 cells. Expression 223 
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of caspase-3 and caspase-9 was significantly decreased in ARPE-19 cells pre-treated with 224 
carnosic acid (10µM) when compared to cells treated with acrylamide alone (Fig. 3).  225 
 226 
3.3 Carnosic acid suppressed acrylamide-induced reactive oxygen species (ROS) 227 
production 228 
We investigated whether acrylamide treatment can increase intracellular ROS in ARPE-19 229 
cells. As shown in Fig. 4, cells treated with 0.7mM and 1mM acrylamide exhibited notably 230 
increased ROS by 32.02% and 34.83% respectively compared with untreated control cells. 231 
Cells pre-treated with carnosic acid (10µM) then treated with acrylamide (0.7 and 1mM) 232 
showed significantly reduced ROS by 15.02% and 17.33% respectively when compared with 233 
cells treated with acrylamide alone. 234 
 235 
3.4 Carnosic acid treatment reverses acrylamide-induced changes in the expression of 236 
antioxidant genes 237 
Acrylamide-induced ROS production is possibly due to cellular antioxidant imbalance, so we 238 
examined expression of antioxidant genes in ARPE-19 cells exposed to acrylamide. We 239 
found expression of antioxidant genes was decreased in acrylamide-treated cells compared 240 
to untreated cells (Fig. 5). Compared to the control group, expression of SOD1 gene was 241 
decreased by 50.24% following 0.7mM acrylamide treatment and by 56.58% following 1mM 242 
acrylamide treatment; GPX1 gene expression was decreased by 29.47% and 37.66% 243 
respectively; CAT gene expression was decreased by 47.80% and 52.27% respectively; 244 
NQO-1 gene expression was decreased by 33.67% and 53.04% respectively (although in the 245 
former case the difference was not statistically significant); and GCLM gene expression was 246 
decreased by 27.34% and 36.31% respectively (although in both cases the difference was 247 
not statistically significant).  ARPE-19 cells pre-treated with carnosic acid (10µM) showed 248 
notably increased expression of these genes compared to cells treated with acrylamide 249 
alone: SOD1 expression was increased by 542.6% (pre-treatment with carnosic acid 250 
followed by treatment with acrylamide (0.7mM)) and 577.84% (pre-treatment with carnosic 251 
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acid followed by treatment with acrylamide (1.0mM)); GPX1 expression was increased by 252 
384.2% and 304.13% respectively; CAT expression was increased by 457.66% and 418.39% 253 
respectively; NQO-1 expression was increased by 352.93% and 429.3% respectively; and 254 
GCLM expression was increased by 343.1% and 353.27% respectively (Fig.5). 255 
      We also investigated the effects of carnosic acid on SOD and CAT activities. As shown in 256 
Fig. 6, ARPE-19 cells treated with acrylamide at 0.7 or 1.0mM had SOD activities that were 257 
significantly reduced by 60.75% and 82.26% respectively, and for CAT by 23.86% and 258 
48.6% respectively, when compared to untreated control cells. Pre-treatment with carnosic 259 
acid at 10µM resulted in significantly increased activities of SOD by 512.1% following 260 
treatment with acrylamide (0.7mM) and by 665.35% following treatment with acrylamide 261 
(1.0mM) and increased activity of CAT by 33.68% and 19.49% respectively, when compared 262 
to cells treated with acrylamide alone (Fig. 6A and B). 263 
 264 
3.5 Carnosic acid treatment reverses acrylamide-induced changes in the production of 265 
glutathione and malondialdehyde 266 
Acrylamide treatment can cause decreased glutathione (GSH) and increased 267 
malondialdehyde (MDA) in cell lines and in animal models (Kahkeshani et al., 2015). We 268 
investigated the levels of GSH and MDA in acrylamide-treated ARPE-19 cells and found that 269 
GSH was significantly decreased by 37.39% (0.7mM acrylamide treatment) and 65.02% 270 
(1mM acrylamide treatment) compared to the untreated cells. ARPE-19 cells pre-treated with 271 
carnosic acid (10µM) had significantly increased GSH by 247.24% (0.7 mM acrylamide 272 
treatment) and 261.26% (1.0 mM acrylamide treatment), when compared to cells treated 273 
solely with acrylamide (Fig. 6C). 274 
Production of MDA in ARPE-19 cells treated with acrylamide at 0.7 or 1.0mM was increased 275 
by 22.8% and 27.42% respectively, when compared to the untreated control cells. Pre-276 
treatment with carnosic acid (10 µM) led to decreased levels of MDA by 14.99% (0.7mM 277 
acrylamide treatment) and 17.22% (1.0mM acrylamide treatment) when compared to cells 278 
treated with acrylamide alone (Fig. 6D). 279 
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3.6 Carnosic acid reverses acrylamide-induced changes in the expression of NRF2 280 
gene 281 
NRF2 is known to play an important role in protection against oxidative stress by enhancing 282 
the expression of antioxidant enzyme genes (Kobayashi and Yamamoto, 2006). Knockdown 283 
of NRF2 in PC12 cells further decreased the generation of GSH and increased MDA 284 
production induced by acrylamide (Pan et al., 2016). Firstly we examined expression of 285 
NRF2 gene by qRT-PCR (Fig. 7A) and found acrylamide exposure (0.7 or 1mM) caused 286 
significantly decreased expression of NRF2 by 45.50% and 51.43% respectively, when 287 
compared to the untreated control cells. However, pre-treatment with carnosic acid (10µM) 288 
induced a significant increase in NRF2 expression by 432.65% (0.7mM acrylamide 289 
treatment) and 433.18% (1.0mM acrylamide treatment), when compared to cells treated 290 
solely with acrylamide (Fig. 7B). Secondly we examined NRF2 protein level by western 291 
blotting using anti-NRF2 antibody (Fig. 7C) and found the level of NRF2 protein was 292 
significantly decreased by 65.15% and 82.68% in ARPE-19 cells treated with acrylamide at 293 
0.7 and 1.0mM respectively, when compared to untreated control cells. ARPE-19 cells, pre-294 
treated with carnosic acid (10 µM) and then treated with acrylamide (0.7 or 1.0mM), had a 295 
significant increase in NRF2 protein by 423.33% and 629.21% respectively, compared to 296 
cells treated solely with acrylamide (Fig. 7D). 297 
 298 
Discussion 299 
Humans can be chronically exposed to acrylamide through the intake of certain foods (such 300 
as bread, cereals, potato chips and crisps, and coffee) cooked or heated at high 301 
temperatures. Workers exposed occupationally to acrylamide exhibited peripheral and 302 
central neuropathies (Pennisi et al., 2013).  Tunnel workers exposed to N-303 
methylolacrylamide and acrylamide experienced decreased light sensitivity and colour 304 
discrimination (Goffeng et al., 2008a). Electroretinographic assessment of these workers 305 
showed that cone photoreceptor function was significantly affected (Goffeng et al., 2008b). 306 
Adult rodents and primates exposed to acrylamide showed visual function defects (Merigan 307 
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et al., 1985; Ali et al., 2014). Following maternal exposure to acrylamide or acrylamide-308 
containing fried potato chips, rat offspring showed morphologically abnormal retinal pigment 309 
epithelium (RPE) cells, photoreceptors and ganglion cells (El-Sayyad et al., 2011; Sakr et al., 310 
2011). However, information about acrylamide-induced toxicity in RPE cells and the effects 311 
of carnosic acid on acrylamide-induced toxicity is very limited.       312 
      Our current study used ARPE-19 cells as an in vitro model to assess the toxicity of 313 
acrylamide and evaluate the protective effects of 24 hours of pre-treatment with carnosic 314 
acid. Dietary polyphenols can undergo degradation in cell culture conditions (Xiao and 315 
Högger, 2014) but carnosic acid in ethanolic solutions is fairly stable, degrading by less than 316 
20% after 24 hours (Zhang et al., 2012). Previous studies have shown that acrylamide 317 
exposure caused significantly decreased cell viability and increased ROS production in 318 
neurally-associated cell lines such as PC12, SH-SY5Y, U-1240 MG, U-87 MG and U-251 319 
MG cells (Chen et al., 2009; Chen et al., 2013; Lee et al., 2014; Mehri et al., 2012; Pan et al., 320 
2016; Sumizawa and Igisu, 2007). Acrylamide also inhibited the differentiation and 321 
proliferation of SH-SY5Y and U-1240 MG cells (Chen and Chou, 2015) and promoted 322 
endothelial cell (HUVEC) ageing (Sellier et al., 2015).  Our results also demonstrated that 323 
acrylamide exposure resulted in dose-dependent decreased cell viability (Fig. 1A) and 324 
increased ROS production (Fig. 4). Acrylamide-induced cell death was thought to be 325 
caspase-3 dependent; elevated caspase-3 activities have been reported in acrylamide-326 
exposed SH-SY5Y, PC12 and Caco-2 cells (Pan et al., 2016; Rodríguez-Ramiro et al., 2011; 327 
Sumizawa and Igisu, 2007), A recent study showed that acrylamide-induced cell death was 328 
mediated by ER stress and associated eIF2α-ATF4-CHOP signalling pathway (Komoike & 329 
Matsuoka, 2016).  Our data showed that acrylamide exposure caused marked cell death in 330 
RPE cells, possibly through the caspase-3 dependent pathway (Figs. 2 and 3) although we 331 
cannot exclude the involvement of other cell death pathways in acrylamide-treated RPE 332 
cells.   333 
      Increased ROS production in acrylamide-exposed cells is due to the disruption of redox 334 
homeostasis. Acrylamide exposure resulted in significantly decreased GSH level and 335 
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antioxidant enzyme activities in in vitro mammalian cells and in in vivo animal models (Ali et 336 
al., 2014; Kahkeshani et al., 2015; Lakshmi et al., 2012; Mehri et al., 2015; Pan et al., 2016; 337 
Rodríguez-Ramiro et al., 2011). MDA, a marker for lipid peroxidation and oxidative stress, 338 
was also overproduced in acrylamide-exposed cells and animals (Ali et al, 2014; Mehri et al, 339 
2015; Pan et al, 2016). We too found that RPE cells exposed to acrylamide had notably 340 
decreased GSH and antioxidant enzyme (SOD and catalase) activities, and MDA was also 341 
significantly increased (Fig. 6), suggesting acrylamide treatment caused the redox imbalance 342 
in RPE cells.  343 
      Carnosic acid has shown a protective role in cancer, vascular diseases, 344 
neurodegenerative diseases, metabolic disorders and organ injuries (Bahri et al., 2016). 345 
Carnosic acid protected retinal cells from H2O2-induced oxidative damage in vitro and from 346 
light-induced retinal degeneration in vivo (Rezaie et al., 2012); Administration of carnosic 347 
acid in rd10 mouse model of retinitis pigmentosa suppressed photoreceptor degeneration 348 
(Kang et al., 2016). NRF2 has been involved in carnosic acid-mediated neuroprotection 349 
(Kang et al., 2016; Rezaie et al., 2012; Satoh et al., 2008). Carnosic acid treatment resulted 350 
in NRF2 upregulation in cortical neurons, retinal cells and tissues (Kang et al., 2016; Rezaie 351 
et al., 2012; Satoh et al., 2008).  NRF2 signal pathway also mediated acrylamide-induced 352 
apoptosis in PC12 cells (Pan et al., 2016). Our results demonstrated that acrylamide 353 
exposure downregulated NRF2 expression in RPE cells and that carnosic acid treatment 354 
reversed this effect (Fig. 7).  Acrylamide exposure also downregulated the expression of 355 
NFR-targeting antioxidant genes (SOD1, GPX1, catalase, NQO1 and GCLM) (Fig. 5); again, 356 
carnosic acid treatment was able to reverse these effects. 357 
      In summary, our results suggest that carnosic acid can protect RPE cells from 358 
acrylamide-induced oxidative damages through NRF2 signalling pathway and has a potential 359 
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Table 1 The primers used for qRT-PCR 552 
Gene Forward primers 5′-3′  
 
Reverse primers 5′-3 Annealing 
temperature °C 




NRF2 AGTGGATCTGCCAACTACTC CATCTACAAACGGGAATGTCTG 56.5 106 (Clements et al., 
2006) 
GPX 1 AGTCCACCGTGTATGCCTTC CTCCTGGTGTCCGAACTGAT 57.0 218 Designed in lab 
SOD 1 AGGGCATCATCAATTTCGAG CATTGCCCAAGTCTCCAAC 55.0 217 Designed in lab 
CAT ATCTCGTTGGAAATAACACC AGAAACCTGATGCAGAGACT 57.5 161 Designed in lab 
NQO-1 CCTCTATGCCATGAACTT TATAAGCCAGAACAGACTC 48.6 107 Qaisiya et al,2013 
GCLM GCCATAGGTACCTCTGATC CTTGACAGACAACATACTGTC 51.2 487 Rezaie et al,2012 
CASPASE 3 AACTGGACTGTGGCATTG ACCAGGTGCTGTGGAGTA 54.3 107 Zhou et al., 2008 
CASPASE 9 ATGGACGAAGCGGATCGGCGGCTCC GCACCACTGGGGTAAGGTTTTCTAG 64 331 Ceruti et al., 2005 





















Figure legends 571 
Figure 1 The effects of acrylamide (ACR) and carnosic acid (CA) on cell viability.  (A) Dose-572 
dependent decreases in cell viability in ARPE-19 cells treated with ACR at different 573 
concentrations. (B) Dose-dependent decreases in cell viability in ARPE-19 cells treated with 574 
CA at different concentrations. (C) Microscopic images of ARPE-19 cells exposed to ACR 575 
and / or CA. (D) CA pre-treatment in ARPE-19 cells reversed ACR-caused toxic effects.  All 576 
data are presented as the means± standard error of three independent experiments. 577 
Statistical significance was analysed using on-way ANOVA test. UT, untreated control cells; 578 
ns, no significance; **P <0.01, ***P<0.001, ****P<0.0001. (E) Structure of acrylamide and 579 
carnosic acid. 580 
 581 
Figure 2 Significant increases of apoptosis in ACR-exposed ARPE-19 cells detected by a 582 
TUNEL assay. (A) Nuclei of apoptotic cells were stained in green. Cells treated with DNase 583 
were used as positive control for apoptosis. ARPE-19 cells were exposed to 0.7 or 1mM of 584 
ACR only,  or 0.7 mM ACR + 10 µM CA, or 1 mM ACR + 10 µM CA for 24 hours then stained 585 
with TUNEL reagents and DAPI to detect apoptotic cells. (B) Quantification of apoptotic cell 586 
number in 300 cells (in percentage). All data are presented as the means± standard error of 587 
three independent experiments. Statistical significance of apoptotic cells between each group 588 
was analysed using one-way ANOVA test. **P<0.01, ***P<0.001, ****P<0.0001. 589 
 590 
Figure 3 ACR exposure led to notably increased expression of caspase 3 and 9, pre-591 
treatement with CA reversed the effects. (A) Agarose gel electrophoresis of qRT-PCR 592 
products. (B) Expression levels of caspase 3 in ARPE-19 cells treated with ACR only for 24 h 593 
or pre-treated with CA then treated with ACR for 24 h were measured by qRT-PCR. (C) 594 
Expression levels of caspase 9 in ARPE-19 cells treated with ACR only for 24 h or pretreated 595 
with CA then treated with ACR for 24 h were measured by qRT-PCR. All data are presented 596 
as the means± standard error of three independent experiments. Statistical significance of 597 
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expression of caspase3 and 9 was analysed using one-way ANOVA test. UT, untreated 598 
control cells; ns, no significance; *P>0.05, **P<0.01, ***P<0.001, ****P<0.0001.  599 
 600 
Figure 4 Pre-treatment with CA suppressed ACR-induced ROS production. ARPE-19 cells 601 
were exposed to ACR only or pre-treated with CA then treated with ACR. ROS production 602 
was measured using DCFH-DA staining. All data are presented as the means± standard 603 
error of three independent experiments. Statistical significance was analysed using on way 604 
ANOVA test. UT, untreated control cells; ***P<0.001, ****P<0.0001. 605 
 606 
Figure 5 ACR exposure led to notably decreased expression of antioxidant genes and pre-607 
treatment with CA reversed the effects. (A) Agarose gel electrophoresis of qRT-PCR 608 
products. Expression levels of SOD1 (B), GPX1 (C), catalase (D), NQO-1 (E) and GCLM in  609 
ARPE-19 cells treated with ACR only for 24 h, or pre-treated with CA then treated with ACR 610 
for 24 h, were measured by qRT-PCR. All data are presented as the means± standard error 611 
of three independent experiments. Statistical significance of expression of these anti-oxidant 612 
genes was analysed using one way ANOVA test UT, untreated control cells; ns, no 613 
significance; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.  614 
 615 
Figure 6 CA treatment reversed ACR-induced effects on the activities of SOD and catalase, 616 
the level of GSH and MDA. Activities of SOD (A) and catalase (B) were significantly 617 
decreased in ARPE-19 cells challenged with ACR only for 24 h, and notably increased when 618 
pre-treated with CA. (C) The generation of GSH was significantly decreased in ARPE-19 619 
cells challenged with ACR only for 24 h, and notably increased when pre-treated with CA. (D) 620 
MDA production was significantly increased in ARPE-19 cells challenged with ACR only for 621 
24 h, and notably decreased when pre-treated with CA. All data are presented as the 622 
means± standard error of three independent experiments. Statistical significance was 623 
analysed using one-way ANOVA test. UT, untreated control cells. *P<0.05, **P<0.001, 624 
***P<0.001, ****P<0.0001).  625 
24 
 
Figure 7 ACR exposure downregulated the expression of NRF2 and pre-treatment with CA 626 
reversed the effects. (A) Agarose gel electrophoresis of qRT-PCR products. (B) Expression 627 
levels of NRF2 in ARPE-19 cells treated with ACR only for 24 h or pre-treated with CA then 628 
treated with ACR for 24 h were measured by qRT-PCR. (C) Protein levels of NRF2 in ARPE-629 
19 cells treated with ACR only for 24 h or pre-treated with CA then treated with ACR for 24 h 630 
were examined by western blotting. (D) Quantification of NRF2 protein levels normalized with 631 
GAPDH protein. All data are presented as the means± standard error of three independent 632 
experiments. Statistical significance was analysed using one-way ANOVA test. UT, untreated 633 
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